Information Provided By: 
Fly News Breaks for March 11, 2016
SNY, VCYT
Mar 11, 2016 | 08:59 EDT
After Veracyte (VCYT) reported weaker than expected Q4 results, Cantor says that the termination of its deal with Sanofi (SNY) will improve its profitability significantly. The firm adds that Veracyte's deal with Health Care Service Corporation should significantly increase Veracyte's volumes in 2016. It calls Veracyte's valuation "compelling" and recommends that investors buy the shares on any weakness. It keeps a Buy rating on the shares.
News For VCYT;SNY From the Last 2 Days
There are no results for your query VCYT;SNY
